Compounds > mk 912
Page last updated: 2024-09-03

mk 912 and substance p, sar(9)-met(o2)(11)-

mk 912 has been researched along with substance p, sar(9)-met(o2)(11)- in 1 studies

Compound Research Comparison

Studies
(mk 912)		Trials
(mk 912)		Recent Studies (post-2010)
(mk 912)		Studies
(substance p, sar(9)-met(o2)(11)-)		Trials
(substance p, sar(9)-met(o2)(11)-)		Recent Studies (post-2010) (substance p, sar(9)-met(o2)(11)-)
603215106

Protein Interaction Comparison

ProteinTaxonomymk 912 (IC50)substance p, sar(9)-met(o2)(11)- (IC50)
Substance-P receptorHomo sapiens (human)0.0006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, CC; Jolicoeur, P; Lachance, N; Rasori, R; Robichaud, A; Savoie, C; Stamatiou, PB1

Other Studies

1 other study(ies) available for mk 912 and substance p, sar(9)-met(o2)(11)-

ArticleYear
Assessing the emetic potential of PDE4 inhibitors in rats.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Male; Pentobarbital; Phosphodiesterase Inhibitors; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Neurokinin-3; Substance P; Vomiting

2002